TAK
TAKEDA PHARMACEUTICAL CO LTD
NYSE: TAK · Tokyo, M0 · Healthcare
$17.06-0.49 (-2.79%)Closed
Market Cap$26.58B
Cash—most recent
Runway—
P/E (TTM)—
52-Wk Range$13.23 – $18.80
Avg Volume3.0M3-month
Price & Trading Activity

Daily close with catalyst overlays and trading volume

$17.06+33.6%
Pipeline

Drug candidates sponsored by TAKEDA PHARMACEUTICAL · ClinicalTrials.gov

0 drugs · 0 trials
No trials found for this sponsor.
Valuation

Risk-adjusted NPV

Loading pipeline…
Peer comparison

Cohort check

No peer cohort defined for TAK. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.